This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Enovix price target lowered to $25 from $30 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Enovix (ENVX) to $25 from $30 and keeps an Overweight rating on the shares. Enovix missed the mark in Q3, reporting a cycle life issue with battery samples that led to a roughly one-quarter qualification push-out with its first smartphone customer, Honor, the analyst tells investors in a research note. Enovix is confident that commercial smartphone production will begin in Q2, Cantor notes, adding that the company is progressing nicely with smartphone OEMs and toward mass commercialization.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVX:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
